Works by Cho, Bo

Results: 103
    1
    2
    3
    4
    5

    Characterization of Monoclonal Thyroid-Stimulating and Thyrotropin Binding-Inhibiting Autoantibodies from a Hashimoto’s Patient Whose Children Had Intrauterine and Neonatal Thyroid Disease.

    Published in:
    Journal of Clinical Endocrinology & Metabolism, 1997, v. 82, n. 12, p. 3998, doi. 10.1210/jcem.82.12.4433
    By:
    • KOHN, LEONARD D.;
    • KOICHI SUZUKI;
    • HOFFMAN, WILLIAM H.;
    • DONATELLA TOMBACCINI;
    • CLAUDIO MARCOCCI;
    • NAOKI SHIMOJO;
    • YUKIHIKO WATANABE;
    • NOBUYUKI AMINO;
    • BO YOUN CHO;
    • YOICHI KOHNO;
    • AIZAN HIRAI;
    • KAZUO TAHARA
    Publication type:
    Article
    6
    7
    8

    Efficacy and safety of enavogliflozin, a novel SGLT2 inhibitor, in Korean people with type 2 diabetes: A 24‐week, multicentre, randomized, double‐blind, placebo‐controlled, phase III trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 7, p. 1865, doi. 10.1111/dom.15046
    By:
    • Kwak, Soo Heon;
    • Han, Kyung Ah;
    • Kim, Kyung‐Soo;
    • Yu, Jae Myung;
    • Kim, EunSook;
    • Won, Jong Chul;
    • Kang, Jun Goo;
    • Chung, Choon Hee;
    • Oh, Seungjoon;
    • Choi, Sung Hee;
    • Won, Kyu Chang;
    • Kim, Sin Gon;
    • Cho, Seung Ah;
    • Cho, Bo Young;
    • Park, Kyong Soo
    Publication type:
    Article
    9
    10
    11
    12

    A Possible Association Between Thyroid Cancer and Breast Cancer.

    Published in:
    Thyroid, 2015, v. 25, n. 12, p. 1330, doi. 10.1089/thy.2014.0561
    By:
    • An, Jee Hyun;
    • Hwangbo, Yul;
    • Ahn, Hwa Young;
    • Keam, Bhumsuk;
    • Lee, Kyu Eun;
    • Han, Wonshik;
    • Park, Do Joon;
    • Park, In Ae;
    • Noh, Dong-Young;
    • Youn, Yeo-Kyu;
    • Cho, Bo Youn;
    • Im, Seock-Ah;
    • Park, Young Joo
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34

    Postoperative biochemical remission of serum calcitonin is the best predictive factor for recurrence-free survival of medullary thyroid cancer: a large-scale retrospective analysis over 30 years.

    Published in:
    Clinical Endocrinology, 2016, v. 84, n. 4, p. 587, doi. 10.1111/cen.12852
    By:
    • Jung, Kyong Yeun;
    • Kim, Seok‐Mo;
    • Yoo, Won Sang;
    • Kim, Bup‐Woo;
    • Lee, Yong Sang;
    • Kim, Kyung Won;
    • Lee, Kyu Eun;
    • Jeong, Jong Ju;
    • Nam, Kee‐Hyun;
    • Lee, Se Hoon;
    • Hah, Jeong Hun;
    • Chung, Woong Youn;
    • Yi, Ka Hee;
    • Park, Do Joon;
    • Youn, Yeo‐Kyu;
    • Sung, Myung‐Whun;
    • Cho, Bo Youn;
    • Park, Cheong Soo;
    • Park, Young Joo;
    • Chang, Hang‐Seok
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50